Brazil Halts the Final Stage China Vaccine Trial, Claims Serious Adverse Reaction
The Brazilian National Health Surveillance Agency on Monday announced that it has suspended the clinical trials of China's Sinovac COVID-19 vaccines, citing "serious adverse reactions" that occurred during the testing last month (29 October), But the authority did not provide further details, nor explained why it took more than a week to announce the problem.
Sinovac Biotech has been cooperating with Butantan, an institute at the State of Sao Paulo, to develop COVID-19 vaccines, called CoronaVac. The institute was surprised by ANVISA's decision, said it said was investigating the incident and will held a press conference on Tuesday morning local time.
#China #Brazil #SaoPaulo #SinovacBiotech #Butantan #CoronaVac #ANVISA #COVID19 #WuhanVirus #Vaccine
Source: Stand News #Nov10
https://bit.ly/2H6uwYI
The Brazilian National Health Surveillance Agency on Monday announced that it has suspended the clinical trials of China's Sinovac COVID-19 vaccines, citing "serious adverse reactions" that occurred during the testing last month (29 October), But the authority did not provide further details, nor explained why it took more than a week to announce the problem.
Sinovac Biotech has been cooperating with Butantan, an institute at the State of Sao Paulo, to develop COVID-19 vaccines, called CoronaVac. The institute was surprised by ANVISA's decision, said it said was investigating the incident and will held a press conference on Tuesday morning local time.
#China #Brazil #SaoPaulo #SinovacBiotech #Butantan #CoronaVac #ANVISA #COVID19 #WuhanVirus #Vaccine
Source: Stand News #Nov10
https://bit.ly/2H6uwYI
#WuhanPneumonia #CCPVaccine
#Brazil Health Regulator Condemns China For Not Being Transparent
Brazil health regulator #Anvisa releases a statement, criticising that China’s health authorities were not transparent and didn’t provide any information of the criteria for the approval of the emergency use of COVID-19 vaccine developed by China SinoVac Biotech Ltd since June 2020.
China's #SinoVac is conducting the phase 3 tests in different locations, such as Brazil, Indonesia and Turkey, but it doesn’t publish any testing result and efficacy of the vaccine.
The vaccine trial had been suspended because one of the volunteers died. After investigation, the authorities claimed the cause of death was "not related" to the vaccine.
Source: NOW news #Dec15
https://news.now.com/home/international/player?newsId=416739
#Brazil Health Regulator Condemns China For Not Being Transparent
Brazil health regulator #Anvisa releases a statement, criticising that China’s health authorities were not transparent and didn’t provide any information of the criteria for the approval of the emergency use of COVID-19 vaccine developed by China SinoVac Biotech Ltd since June 2020.
China's #SinoVac is conducting the phase 3 tests in different locations, such as Brazil, Indonesia and Turkey, but it doesn’t publish any testing result and efficacy of the vaccine.
The vaccine trial had been suspended because one of the volunteers died. After investigation, the authorities claimed the cause of death was "not related" to the vaccine.
Source: NOW news #Dec15
https://news.now.com/home/international/player?newsId=416739
Brazilian Health Authorities Criticise the Low Transparency of the Chinese Vaccine Emergency Use Standard
Whether using vaccine manufactured by the Chinese company Sinovac Biotech caused controversy in Brazil again and involved in Brazilian partisan debate.
ANVISA, a Brazilian Health Regulatory Agency, expressed their concerns over the COVID-19 vaccines on Monday as the Chinese public health departments approved the vaccine for emergency use without adequate transparency of the policy standards.
Jair Bolsonaro, the President of Brazil, has always criticised the Chinese vaccine that the “origin” of vaccine is not trustworthy. However, his political opponent, Sao Paulo Governor João Doria, who is regarded as the most capable of challenging the presidency in the 2022 presidential election, his state's research institute, is currently developing the vaccine CoronaVac with Sinovac. Doria even mentioned that they expect to distribute the vaccines to the local residents in January 2021.
#Vaccine #COVID19 #CovidVaccine #JoĂŁoDoria #JairBolsonaro #SinovacBiotech #Brazil #ANVISA
Source: Stand News #Dec15
https://bit.ly/3ucWGEW
Whether using vaccine manufactured by the Chinese company Sinovac Biotech caused controversy in Brazil again and involved in Brazilian partisan debate.
ANVISA, a Brazilian Health Regulatory Agency, expressed their concerns over the COVID-19 vaccines on Monday as the Chinese public health departments approved the vaccine for emergency use without adequate transparency of the policy standards.
Jair Bolsonaro, the President of Brazil, has always criticised the Chinese vaccine that the “origin” of vaccine is not trustworthy. However, his political opponent, Sao Paulo Governor João Doria, who is regarded as the most capable of challenging the presidency in the 2022 presidential election, his state's research institute, is currently developing the vaccine CoronaVac with Sinovac. Doria even mentioned that they expect to distribute the vaccines to the local residents in January 2021.
#Vaccine #COVID19 #CovidVaccine #JoĂŁoDoria #JairBolsonaro #SinovacBiotech #Brazil #ANVISA
Source: Stand News #Dec15
https://bit.ly/3ucWGEW